![Page 1: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/1.jpg)
Infection Control
and antimicrobial resistance
Evelina Tacconelli
Infectious Diseases
Tuebingen University
Germany
![Page 2: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/2.jpg)
Preventing MDR-Gram positive
Open or closed issues?
• Targeted screening vs universal screening
• PCR vs conventional cultures (screening)
• Room isolation / contact precaution vs no CP
• Target vs universal decolonisation
![Page 3: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/3.jpg)
Preventing MDR-Gram negative
Open or closed issues?
• Best combination of interventions
• CP for patients colonised or infected with ESBL-E. coli • Chlorexidine bath
• Decolonisation
![Page 4: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/4.jpg)
Preventing MDR
Open or closed issues?
• Antimicrobial stewardship programme
• Impact of the increase of elderly population
• Outcome assessment
• PUBLIC-PRIVATE COLLABORATIVE RESEARCH
![Page 5: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/5.jpg)
Quezada, AAC 2012
![Page 6: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/6.jpg)
Schinasi L, (2013)
![Page 7: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/7.jpg)
Fuller, Plos One Sept 2013
![Page 8: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/8.jpg)
Fuller, Plos One Sept 2013
![Page 9: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/9.jpg)
Tacconelli, Lancet Infect Dis, 2009
Type of tests
Molecular vs Cultures
![Page 10: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/10.jpg)
1. Isolation + decolonization
reduces transmission by
64%
2. Undetected MRSA-positive
patients were estimated to
be the source of 75% of total
transmission events.
3. Isolation measures
combined with
decolonization treatment
were strongly associated
with a reduction in MRSA
transmission in hospital
general wards.
Worby, Am J Ep April 2013
![Page 11: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/11.jpg)
Universal decolonisation
Huang, NEJM, June 2013
3 groups
universal screening
+ isolation
universal screening
+ isolation +
decolonisation
universal
decolonisation
(chlorexidine +
mupirocin)
One BSI infection
was prevented per
54 patients who
underwent
decolonisation
![Page 12: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/12.jpg)
Shweizer, BMJ 2013
![Page 13: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/13.jpg)
• 5726 patients included
• BSI due to MRSA
• 1.8 x 1,000 hospital-admission
• BSI due to ESBL+
Enterobacteriaceae
• 3.1 x 1,000 hospital-admission
Tacconelli, ECCMD 2012, 2013
http://www.saturn-project.eu/
![Page 14: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/14.jpg)
Chairperson: Evelina Tacconelli (Tuebingen, Germany)
• Barry Cookson (Health Protection Agency, London, UK)
• Stephanie Dancer (Hairmyres Hospital, East Kilbride,
Lanarkshire, UK)
• Uwe Frank (Heidelberg University Hospital, Heidelberg,
Germany)
• Gunnar Kahlmeter (Central Hospital, Växjö, Sweden)
• Jesus Rodrigues Bano (Hospital Universitario Virgen
Macarena, Sevilla, Spain)
• Nalini Singh / Deborak Yokoe (USA)
Tacconeli, CMI, under publication (free access)
![Page 15: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/15.jpg)
Multifaceted strategy effectiveness for MDR-GN
Tacconelli et al, under revision
HH
Education
CP
Combinations of interventions significantly
associated with effectiveness
HH
Education
CP
Isolation room
OR = 6.1 OR = 8.3
![Page 16: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/16.jpg)
Chlorexidine bathing
Climo NEJM 2013
![Page 17: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/17.jpg)
Tacconelli, AAC, 2009
Risk of MRSA new acquisition after antibiotic therapy in hospitalized patients
![Page 18: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/18.jpg)
Cochrane review (P. Davey 2013)
• The main comparison was between persuasive and
restrictive methods.
• Overall, the 89 studies showed that the methods improved
prescribing.
• 21 studies showed that the methods decreased the number
of infections in hospital.
• The restrictive methods appeared to have a larger effect
than persuasive methods.
![Page 19: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/19.jpg)
ESCMID Guidelines
to control the spread of MDR-GNB 2013
• Epidemic setting: 17 interventions
• Endemic setting: 7 interventions
• Moderate level of evidence / strong recommendations for:
• MDR-A. baumannii (epidemic setting)
• ESBL-producing Enterobacteriaceae (endemic setting)
![Page 20: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/20.jpg)
1. University Hospital
Freiburg, Germany (WP
1-3, 8)
2. Mater Dei Hospital,
Msida, Malta (WP 4)
3. Institute of Public Health,
Brussels, Belgium (WP
5)
4. Università Cattolica,
Rome, Italy (WP 6)
5. Radboud University
Nijmegen Medical
Centre, The Netherlands
(WP 7)
Only 56% of ICU have an ATBS
![Page 21: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/21.jpg)
Definition of effectiveness of ATBS
New parameters
• resistance rate x 1000 HA / DH
• mortality attributable to infection
• overall length of hospitalization
• periods spent in specific care areas such as the ICU’s
• hospitalisation within 1 months
• rates of recurrent infection
• the frequency with which specific laboratory
studies are performed
• antibiotic usage patterns, and institutional
antimicrobial resistance patterns.
Lack of agreement about outocome indicators / heterogeneity of reports
![Page 22: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/22.jpg)
Decolonisation
• 6 CT
• 2 RCT
• 1 KRKP
• No evidence to recommend decolonisation to reduce the
spreading of ESBL-producing bacteria
![Page 23: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/23.jpg)
![Page 24: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/24.jpg)
Major comments
a) International networking and societies should play an
“homogenizing” role
b) Revision and improvement of STROBE items for
epidemiological studies on ARI to improve the quality level of
evidence
c) New studies and agreement on outcome indicators
d) Consensus among clinicians, researchers, epidemiologists,
pharmacologists, pharma companies, governative entities,
control entities on new outcome indicators for clinical
evaluation of new antibiotics
![Page 25: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/25.jpg)
Preventing MDR-Gram positive
Open or closed issues?
• Targeted screening vs universal screening
• PCR vs conventional cultures (screening)
• Room isolation / contact precaution vs no CP
• Target vs universal decolonisation
• Decolonisation
![Page 26: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/26.jpg)
Preventing MDR-Gram negative
Open or closed issues?
• Best combination for best effectiveness
• CP for patients colonised or infected with ESBL-E. coli
• Chlorexidine bath
• Decolonisation
![Page 27: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/27.jpg)
Preventing MDR
Open or closed issues?
• Antimicrobial stewardship programme
• Impact of the increase of elderly population
• Outcome assessment
• PUBLIC-PRIVATE COLLABORATIVE RESEARCH
![Page 28: Infection Control and antimicrobial resistance](https://reader036.vdocument.in/reader036/viewer/2022071506/62cfad1c52a7f127780969ad/html5/thumbnails/28.jpg)
Is there any country doing good?